Validated enantiospecific LC method for determination of (R)-enantiomer impurity in (S)-efavirenz

Pharmazie

Volumn 63, Issue 2, 2008, Pages 107-109

  Seshachalam, Unnam ^a   Narasimha Rao, D V L ^a   Chandrasekhar, K B ^b  

^a Matrix Laboratories Limited   (India)

^b JNTUA COLLEGE OF ENGINEERING   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ;

ACCURACY; ARTICLE; DRUG IMPURITY; DRUG PURITY; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STEREOSPECIFICITY;

ANTI-HIV AGENTS; BENZOXAZINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; PARTICLE SIZE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET; STEREOISOMERISM;

EID: 39449133006     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.7208     Document Type: Article

References (9)

1. Adkins JC, Noble S. (1998) Efavirenz. Drugs 56: 1055-1064.
2. Lavison G, Thiébaut D (2003) Evaluation of a ristocetin bonded stationary phase for subcritical fluid chromatography of enantiomers. Chirality 15: 630-636.
3. Montgomery ER, Edmanson AL, Cook SC, Hovsepian PK (2001) Development and validation of a reverse-phase HPLC method for analysis of efavirenz and its related substances in the drug substance and in a capsule formulation. J Pharm Biomed Anal 25: 267-284.
4. Okamoto Y, Kaida Y (1994) Resolution by high-performance liquid chromatography using polysaccharide carbamates and benzoates as chiral stationary phases. J Chromatogr A 666: 403-419.
5. Okamoto Y, Yashima E (1998) Polysaccharide derivatives for chromatographic separation of enantiomers. Angew Chem Int Ed 37: 1020-1043.
6. Weissburg RP, Montgomery ER, Junnier LA, Segretario J, Cook SC, Hovsepian PK (2002) Investigation of critical factors for the resolution of SR695, a key impurity, from efavirenz in the reversed-phase assay of efavirenz dosage forms. J Pharm Biomed Anal 28: 45-56.
7. Xu JQ, Aubry AF (2003) Impurity profiling of non-nucleoside reverse transcriptase inhibitors by HPLC using a porous graphitic carbon stationary phase. Chromatographia 57: 67-71.
8. Yashima E, Yamamoto C, Okamoto Y (1998) Polysaccharide-based chiral LC columns. Synlett 34: 344-360.
9. Young SD, Britcher SF, Tran LO, Payne LS, Lumma WC, Lyle TA, Huff JR, Anderson PS, Olsen DB, Carroll SS, Pettibone DJ, O'Brien JA, Ball RG, Balani SK, Lin JH, Chen IW, Schleif WA, Sardana VV, Long WJ, Byrnes VW, Emini EA (1995) L-743, 726 (DMP-266): a novel, highly potent non-nucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother 39: 2602-2605.